glp-1 patch clinical trial Boston biotech secures Series A funding to move its once-weekly obesity into first-in-human trials. ㅤ Link in bio. ㅤ #longevity #obesity #glp1 #clinicaltrials #biotech Updated guidance from the PCDS

In practical terms, 76% of semaglutide-treated participants experienced a BMI reduction of 5% (vs

The Effect of a Meditative Movement Intervention on Quality of Sleep in the Elderly: A Systematic Review and Meta-Analysis

doi:10.1007/s00404-018-4861-y Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Di Marco R

Qi-Wei-Du-Wan consists of Shou Ti Huang ( Rehmannia glutinosa ), Shan Chu Yu ( Cornus officinalis ), Shan Yao ( Dioscorea opposita ), Fu Ling ( Wolfiporia extensa ), Mou Tan Pi ( Paeonia suffruticosa ), Tse Hsieh (Alisma plantago-aquatica ), and Wu Wei Zi ( Schisandra chinensis ) [166]

Safety Monitoring and Adverse Event Management Hers providers conduct baseline screening for contraindications and advise patients on common GLP-1 side effects including nausea, vomiting, constipation, and rare pancreatitis risk

Ergo, we should be doing more to protect the ants by avoiding climate change